Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine
Sponsor: Novaliq GmbH
Summary
The objective of this trial is to evaluate the effect of cyclosporine ophthalmic solution, 0.1% on corneal endothelial cell health in comparison to a hypotonic saline solution in subjects with Dry Eye Disease (DED)
Official title: A Multi-center, Randomized, Double-masked, Controlled Clinical Trial to Evaluate the Corneal Endothelial Health of Dry Eye Disease Subjects Treated With Cyclosporine Ophthalmic Solution, 0.1%
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
204
Start Date
2024-04-22
Completion Date
2025-07-30
Last Updated
2026-08-19
Healthy Volunteers
No
Conditions
Interventions
Cyclosporine ophthalmic solution, 0.1%
Colorless and clear opthalmic solution containing 0.1% Cyclosporine
Saline solution, 0.6%
Colorless and clear sodium chloride solution (0.6%)
Locations (6)
CYS-007 Investigational Site
Newport Beach, California, United States
CYS-007 Investigational Site
Torrance, California, United States
CYS-007 Investigational Site
Garner, North Carolina, United States
CYS-007 Investigational Site
Shelby, North Carolina, United States
CYS-007 Investigational Site
Cranberry Township, Pennsylvania, United States
CYS-007 Investigational Site
Memphis, Tennessee, United States